Audience Response. Hypertension. Case: Mr. J. Measuring BP. Non-pharmacologic intervention. Case: Mr. J. Session ID: HTN411

Size: px
Start display at page:

Download "Audience Response. Hypertension. Case: Mr. J. Measuring BP. Non-pharmacologic intervention. Case: Mr. J. Session ID: HTN411"

Transcription

1 Audience Response OR App downloads: Hypertension Chris Knight, MD Session ID: HTN411 Case: Mr. J 52 y/o male patient comes in for evaluation of elevated BP. BP noted to be 148/88 in grocery store, now 138/86 p 84; otherwise healthy, asymptomatic. BMI 28, no regular exercise program. All of these make sense EXCEPT? A. 24-hour ambulatory monitoring B. Dietary counseling C. Exercise recommendations D. Fasting lipids, glucose E. Start hydrochlorothiazide Measuring BP Home BP monitoring 1/2 of patients have home measurements 10 mmhg or more lower than office Better correlated with end organ damage Multiple readings (home or office) more reliable Non-pharmacologic intervention Weight loss: 5-20 mmhg/10 kg DASH diet: 8-14 mmhg Salt restriction: 2-8 mmhg Exercise: 4-9 mmhg Alcohol moderation: 2-4 mmhg Case: Mr. J Mr. J comes back 4 months later. He now goes to the gym twice a week and pays more attention to salt but still eats at restaurants frequently. His LDL is 141, HDL 42. Home BP has been /85-95 for the most part; today his BP is 146/92, p 80. All of these make sense EXCEPT? A. Urinalysis C. Basic metabolic panel D. Albumin/creatinine ratio E. Do them all

2 Prevalence and impact Initial Evaluation Fasting lipids, glucose (Risk factor mod.) 90% lifetime risk at age 55 Risk of CVD doubles for each 20/10 > 115/75 BMP (K+, egfr) UA (for glomerulonephritis) Albumin/creatinine ratio (proteinuria) Consider EKG (for LVH) Case: Mr. J Mr. J reluctantly got his labs (he hates needles): K + 4.1, TC 190, HDL 60, Glucose 89, egfr > 60; Alb/cre ratio 8. The two of you decide to try a medication. Which do you prescribe? A. Amlodipine 5 mg daily B. Chlorthalidone 12.5 mg daily C. Atenolol 25 mg daily D. Hydrochlorothiazide 25 mg daily E. Lisinopril 10 mg daily Treatment Thiazide diuretics are particularly effective Chlorthalidone is twice as potent and has longer 1/2 life than HCTZ, but more hypokalemia ACEI, CCB also well studied as monotherapy CCB requires less monitoring Treatment Amlodipine + ACEI may have additional cardiovascular benefit ß-blockers (esp. atenolol) somewhat less effective at reducing stroke Most effective drug is the one the patient will take: fewer pills, fewer doses are good! Case: Mrs. S A 59 y/o woman with type 2 diabetes comes to your clinic as a new patient. She takes insulin, atorvastatin, and hydrochlorothiazide 25 mg daily for hypertension. Her BP is 133/84, HR 84. Labs show a hemoglobin A1C of 7.1% and urinary albumin/ creatinine ratio of 45. The best next step for her is: A. Home BP monitoring B. Discuss therapeutic lifestyle changes C. Add lisinopril 5 mg daily D. Add atenolol 25 mg daily E. 24-hour urine for protein excretion

3 Targets JNC 7, general: <140/90--but lower (<130)is better if you can get there JNC 7, DM/CKD: <130/80; more important in pts with protenuria Other diseases with lower targets: CHF, Aortic dissection, ASCVD Increased mortality when DBP < 60 with CAD? Specific indications for certain drugs CKD with proteinuria: ACE/ARB CHF: ACE/ARB, ß-blocker, aldosterone antagonists (low dose), diuretics Diabetes: Diuretics, ACE/ARB, ß-blocker, CCB Post-MI: ß-blocker, ACE (ARB?), aldosterone antagonist Case: Mrs. L A 85 y/o woman comes to your office as a new patient to discuss her blood pressure. She has been watching it at home, and it s typically / BMI is 22. She walks for 30 minutes 3 times weekly, eats a low sodium diet, and takes no medications. Your BP target for her would be: A /80-90 B /70-80 C. No evidence to support treatment Hypertension in the Elderly Isolated systolic hypertension more common Data limited in pts over 80; HyVET showed benefit with target 150/80 Beware orthostasis, polypharmacy Reasonable to target /80-90 and adjust target based on comorbidities Case: Mr. C A 75 y/o gentleman comes in for follow-up of hypertension. He is on hydrochlorothiazide 25 mg daily, lisinopril 40 mg daily, and amlodipine 10 mg daily. His blood pressure is sometimes well controlled, others not; today it is 180/100, pulse 64. Your next intervention should be: A. Add clonidine patch, 0.2 mg/day B. Add metoprolol SR 50 mg/day C. Ask him to bring in his pill bottles D. Measure renin/aldosterone ratio E. Check renal artery duplex Resistant hypertension Defined as hypertension that persists despite high doses of three drugs including a diuretic Causes: Drugs: not enough or too many Volume overload Secondary hypertension

4 Drugs: Non-adherence Complex medication regimens Cost concerns Discuss difficulties frequently 1-10 ranking of how likely they are to follow the plan Pill counts Drugs that cause hypertension NSAIDS! Calcineurin inhibitors: cyclosporine, tacrolimus Steroids (and OCPs) Erythropoietin Sympathomimetics: Cocaine, meth, decongestants Herbs: Licorice (real), bitter orange, ephedra Volume overload Excess salt intake Inadequate GFR: consider loop diuretic in CHF, chronic kidney disease Diuretic not given/taken Case: Mrs. P A 32 y/o woman who is 7 months pregnant comes in to see you to stay in touch. BP is 150/90 without proteinuria. The best therapeutic option for her is: A. Hydralazine 10 mg qid B. Methyldopa 250 mg bid C. Labetalol 100 mg bid D. Lisinopril 10 mg qd E. None of the above Hypertension in Pregnancy Mild: 140/90, Severe 160/110 Target: / (concern for placental hypoperfusion) Drugs of choice: Labetalol, Methyldopa, Hydralazine Contraindicated: ACE/ARB Case: Mr. M A 33 y/o gentleman comes in for evaluation of blood pressure. He had a BP of 150/94 noted at a health fair. He brings in an outside lab report that is notable for creatinine 0.9, K+ 3.3, UA normal. Which test is most appropriate?

5 Hyperaldosteronism Hyperaldosteronism Prevalence: 5-15% of hypertensives Symptoms: None Signs: Hypertension & hypokalemia Treatment resistant hypertension Diagnosis Renin/aldosterone ratio 24 hr urine aldosterone (high Na diet) Imaging (CT, Iodocholesterol) Adrenal vein sampling Hyperaldosteronism Management Aldosterone antagonists (less antiandrogenic effects with eplerenone, but $60/mo vs $10-20) Surgery if functional tumor is confirmed Case: Mr. J A 75 y/o man comes in for f/u of his second episode of flash pulmonary edema, now better. BP 154/100, creatinine 1.4 on hydrochlorothiazide and amlodipine. Which test is most appropriate? Renal artery stenosis Renal artery stenosis Prevalence: < 1% of mild hypertension, 10-45% of severe hypertension History: New elevation in BP or creatinine, flash pulmonary edema, atherosclerosis, lack of family history Signs: unilateral abdominal bruit, eye findings of severe hypertension Diagnosis Clinical prediction rule [Krijnen, Annals, 1998] Duplex ultrasonography Angio (MRA, CTA, catheter) MRA not helpful for fibromuscular dyplasia

6 Renal artery stenosis Management ACE/ARB highly effective but need to watch GFR closely in bilateral disease Medical management has equivalent long-term outcomes and better short-term outcomes than intervention Reserve angioplasty or surgery for those who don t respond to medical management Case: Ms. W A 47 y/o woman comes in complaining of hot flashes and dizziness, and occasional headaches. BP is 180/110, p 100 supine, and 140/60, p 128 standing. Which test is most appropriate? Pheochromocytoma Pheochromocytoma Prevalence: < 0.2% of hypertensives Symptoms: Headache, sweating, palpitations, visual blurring, pallor Signs: tachycardia, orthostatic hypotension, hyperglycemia Diagnosis Plasma free metanephrine (sensitive but 10-15% false positives, often due to medications) 24 hr urine metanephrines Imaging (MR, CT, nuclear medicine) Pheochromocytoma Management NO ß-BLOCKERS Surgery is preferred if possible Pre-op BP management with α-blockers, CCBs Manage crises with IV phentolamine or nitroprusside Case: Ms. F A 44 y/o woman comes in for evaluation of high blood pressure. She previously was normotensive, but over the last 2 years has gained 40 lb. and her blood pressure has gone up to 160/100s. She has to use her arms to get out of the chair. Which test is most appropriate?

7 Cushing s syndrome Cushing s syndrome Prevalence: < 0.5% of pts with hypertension History: Weight gain, new diabetes, hypertension Signs: Proximal muscle weakness (specific), cushingoid facies, striae, central obesity Diagnosis Dexamethasone suppression test 24-hr urinary cortisol Overnight cortisol/creatinine ratio Midnight salivary cortisol Cushing s syndrome Management Treatment is surgical if lesion is resectable Ketoconazole, mifepristone, paserotide all used in unresectable disease Case: Mr. K A 34 y/o man comes in for evaluation of fatigue. He reports trouble staying awake while at his desk, and has twice fallen asleep at the wheel. BP is 150/90. Which test is most appropriate? Sleep Apnea Consider sleep apnea in patients with refractory hypertension Raw association is strong (OR 3.8) but becomes more nebulous (OR 1.5, p=ns) when adjusted for comorbidities Small studies suggest treatment may help but limited data in resistant HTN Secondary HTN: Other Causes Coarctation: decreased femoral pulses Oral contraceptives Scleroderma renal crisis (use an ACE!) Hypothyroidism (rare) Hyperparathyroidism (rare)

8 Secondary HTN Principles Use your H&P! It s ok to manage some things medically Be sure to rule out medications (too few/too many) before starting the megaworkup Case: Mr. D A 58 y/o man comes in for evaluation of headache. He reports two days of worsening headache, and now feels foggy. BP is 240/140 and papilledema is present. Which is the best treatment plan? A. Sublingual nifedipine while waiting for medics to arrive B. ICU for IV fenoldopam, target 130/90 C. ICU for IV nitroprusside, target 180/105 D. Amlodipine 10 mg po, recheck 6h E. Furosemide 20 mg po and recheck tomorrow Hypertensive emergency Severe hypertension with acute retinal changes (hemorrhage, exudates, papilledema), acute renal insufficiency, or CNS findings Hypertensive encephalopathy typically nonfocal: headache, nausea, vomiting, altered MS, seizures Hypertensive emergency Treat with IV antihypertensives: nitroprusside, fenoldopam, hydralazine (esp. in eclampsia), labetalol, esmolol, phentolamine Target DBP within a few hours; maximum fall in BP should be 25% of initial measurements More rapid lowering increases risk of ischemia

RESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University

RESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University RESISTENT HYPERTENSION Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University Resistant Hypertension Blood pressure remaining above goal in spite of concurrent use of 3 antihypertensive

More information

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair Difficult-to-Control & Resistant Hypertension Anthony Viera, MD, MPH, FAHA Professor and Chair Objectives Define resistant hypertension Discuss evaluation strategy for patient with HTN that appears difficult

More information

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy Hypertension Update Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy Introduction 1/3 of US adults have HTN More prevalent in non-hispanic

More information

Pharmacologic Management of Hypertension

Pharmacologic Management of Hypertension Current Concepts In Management of Fernando Vega, MD Secondary - Definition Renovascular Disease (The kidney doesn t get impressed by blood pressure) Renovascular stenosis Renal artery stenosis Fibromuscular

More information

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati CHAPTER-I CARDIOVASCULAR SYSTEM Hypertension SUB: PHARMACOTHERAPEUTICS-I CODE:T0820006 Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati Hypertension

More information

Hypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015

Hypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015 Hypertension Update Beverly J. Mathis, D.O. OOA May 2015 Objectives Learn new recommendations for BP treatment goals Approach to hypertension in the office Use of hypertensive drugs, and how to tailor

More information

Treating Hypertension from

Treating Hypertension from Treating Hypertension from Initiation to Resistance: A Case Study Approach Michelle Krause, MD Division of Nephrology University of Arkansas for Medical Sciences Central Arkansas Veteran s Healthcare System

More information

ADVANCES IN MANAGEMENT OF HYPERTENSION

ADVANCES IN MANAGEMENT OF HYPERTENSION Advances in Management of Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Prevalence 29%; Blacks 33.5%

More information

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing

More information

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu

More information

Jared Moore, MD, FACP

Jared Moore, MD, FACP Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner

More information

Hypertension Pharmacotherapy: A Practical Approach

Hypertension Pharmacotherapy: A Practical Approach Hypertension Pharmacotherapy: A Practical Approach Ronald Victor, MD Burns & Allen Chair in Cardiology Director, The Hypertension Center Associate Director, The Heart Institute Hypertension Center 1. 2.

More information

Hypertension Update Background

Hypertension Update Background Hypertension Update Background Overview Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Management Guideline Comparison

More information

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC HypertensionTreatment Guidelines Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC Objectives: Review the definition of the different stages of HTN. Review the current guidelines for treatment of HTN. Provided

More information

Management of Hypertension. Ahmed El Hawary MD Suez Canal University

Management of Hypertension. Ahmed El Hawary MD Suez Canal University Management of Hypertension Ahmed El Hawary MD Suez Canal University Minimal vs. Optimal Care Resources more than science affect type of care and level of management. what is possible (minimal care) and

More information

Approach to patient with hypertension. Dr. Amitesh Aggarwal

Approach to patient with hypertension. Dr. Amitesh Aggarwal Approach to patient with hypertension Dr. Amitesh Aggarwal Definition A systolic blood pressure ( SBP) >139 mmhg and/or A diastolic (DBP) >89 mmhg. Based on the average of two or more properly measured,

More information

How to approach resistant hypertension. Teh-Li Huo, M.D., Ph.D.

How to approach resistant hypertension. Teh-Li Huo, M.D., Ph.D. How to approach resistant hypertension Teh-Li Huo, M.D., Ph.D. BP goals No risk factors:

More information

Hypertension Update. Aaron J. Friedberg, MD

Hypertension Update. Aaron J. Friedberg, MD Hypertension Update Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Background Diagnosis Management Overview Guideline

More information

ADVANCES IN MANAGEMENT OF HYPERTENSION

ADVANCES IN MANAGEMENT OF HYPERTENSION Prevalence 29%; Blacks 33.5% About 72.5% treated; 53.5% uncontrolled (>140/90) Risk for poor control: Latinos, Blacks, age 18-44 and 80,

More information

Managing Hypertension in 2016

Managing Hypertension in 2016 Managing Hypertension in 2016: Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu

More information

Diagnosis and treatment of hypertension. Kari Nelson, MD MSHS Division of General Internal Medicine VA Puget Sound, University of Washington

Diagnosis and treatment of hypertension. Kari Nelson, MD MSHS Division of General Internal Medicine VA Puget Sound, University of Washington Diagnosis and treatment of hypertension Kari Nelson, MD MSHS Division of General Internal Medicine VA Puget Sound, University of Washington Outline Epidemiology Diagnosis Evaluation of individuals with

More information

Preventing and Treating High Blood Pressure

Preventing and Treating High Blood Pressure Preventing and Treating High Blood Pressure: Finding the Right Balance of Integrative and Pharmacologic Approaches Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Blood Pressure

More information

Antihypertensive drugs: I. Thiazide and other diuretics:

Antihypertensive drugs: I. Thiazide and other diuretics: Clinical assessment of hypertensive patient: You have to take history regarding the presence of other risk factors for CAb like diabetes mellitus, smoking, etc. Take history whether the patient takes medications

More information

Hypertension (JNC-8)

Hypertension (JNC-8) Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint

More information

Objectives. JNC 7 Is Nice But What s Up With JNC 8? Why Do We Care? Hypertension Background: Prevalence

Objectives. JNC 7 Is Nice But What s Up With JNC 8? Why Do We Care? Hypertension Background: Prevalence JNC 7 Is Nice But What s Up With JNC 8? 37 th Annual CAPA Conference October 4 th 2013 Ignacio de Artola, Jr. M.D. Assistant Professor of Clinical Family Medicine Medical Director, Primary Care Physician

More information

Update in Hypertension

Update in Hypertension Update in Hypertension Eliseo J. PérezP rez-stable MD Professor of Medicine DGIM, Department of Medicine UCSF 20 May 2008 Declaration of full disclosure: No conflict of interest (I have never been funded

More information

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,

More information

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION Management of Hypertension: Treatment Thresholds and Medication Selection Robert B. Baron, MD MS Professor and Associate Dean Declaration of full disclosure: No conflict of interest Presentation Goals

More information

New Hypertension Guidelines. Kofi Osei, MD

New Hypertension Guidelines. Kofi Osei, MD New Hypertension Guidelines Kofi Osei, MD None Disclosures Objectives The new blood pressure definitions and cardiovascular risk The role to time and location in the diagnosis of hypertension Apply evidence-based

More information

Management of High Blood Pressure in Adults

Management of High Blood Pressure in Adults Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) James, P. A. (2014, February 05). 2014 Guideline for Management

More information

Difficult to Treat Hypertension

Difficult to Treat Hypertension Difficult to Treat Hypertension According to Goldilocks JNC 8 Blood Pressure Goals (2014) BP Goal 60 years old and greater*- systolic < 150 and diastolic < 90. (Grade A)** BP Goal 18-59 years old* diastolic

More information

Modern Management of Hypertension: Where Do We Draw the Line?

Modern Management of Hypertension: Where Do We Draw the Line? Modern Management of Hypertension: Where Do We Draw the Line? Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Blood Pressure

More information

hypertension Head of prevention and control of CVD disease office Ministry of heath

hypertension Head of prevention and control of CVD disease office Ministry of heath hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension

More information

Hypertension Management Controversies in the Elderly Patient

Hypertension Management Controversies in the Elderly Patient Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No

More information

Secondary Hypertension: A Real World Approach

Secondary Hypertension: A Real World Approach Secondary Hypertension: A Real World Approach Evan Brittain, MD December 7, 2012 Kingston, Jamaica Disclosures None Real World Causes Renovascular Hypertension Endocrine Obstructive Sleep Apnea Pseudosecondary

More information

Hypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg

Hypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg Hypertension diagnosis (see detail document) Non-diabetic Diabetic Very elderly (older than 80 years) Target less than 140/90mmHg Target less than 130/80mmHg Consider SBP target less than 150mmHg Non-diabetic

More information

Modern Management of Hypertension

Modern Management of Hypertension Modern Management of Hypertension Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Hypertension Prevalence

More information

SAURIN GANDHI, AZCOM Evidence-Based Guideline for the Management of High Blood Pressure in Adults (JNC 8)

SAURIN GANDHI, AZCOM Evidence-Based Guideline for the Management of High Blood Pressure in Adults (JNC 8) 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults (JNC 8) Background HTN is the most common condition seen in primary care and leads to MI, stroke, renal failure, and death

More information

MANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM

MANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM MANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM Are Particular Anti-hypertensives More Effective or Harmful Than Others in Hypertension in Pregnancy? Existing data is inadequate Methyldopa and

More information

Hypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program

Hypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program Hypertension: JNC-7 Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! Reference Card

More information

Hypertension in the very old. Objectives: Clinical Perspective

Hypertension in the very old. Objectives: Clinical Perspective Harvard Medical School Hypertension in the very old Ihab Hajjar, MD, MS, AGSF Associate Director, CV Research Lab Assistant Professor of Medicine, Harvard Medical School Objectives: Describe the clinical

More information

Approach to Management of Hypertension. Prof. Abdulkareem Al-Suwaida, MD, FRCPC, MSc

Approach to Management of Hypertension. Prof. Abdulkareem Al-Suwaida, MD, FRCPC, MSc Approach to Management of Hypertension Prof. Abdulkareem Al-Suwaida, MD, FRCPC, MSc 442-2018 Objectives of The Lecture Hypertension in KSA New definitions of hypertension Understand how to diagnose hypertension

More information

Reframe the Paradigm of Hypertension treatment Focus on Diabetes

Reframe the Paradigm of Hypertension treatment Focus on Diabetes Reframe the Paradigm of Hypertension treatment Focus on Diabetes Paola Atallah, MD Lecturer of Clinical Medicine SGUMC EDL monthly meeting October 25,2016 Overview Physiopathology of hypertension Classification

More information

Hypertension Management - Summary

Hypertension Management - Summary Who should have blood pressure assessed? Hypertension Management - Summary All patients over the age of 40 years, every 1-3 years in order to determine their cardiovascular risk (ie. Framingham Risk Score)

More information

Diabetes and Hypertension

Diabetes and Hypertension Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for

More information

COMPLEX HYPERTENSION. Anita Ralstin, FNP-BC Next Step Health Consultant, LLC

COMPLEX HYPERTENSION. Anita Ralstin, FNP-BC Next Step Health Consultant, LLC COMPLEX HYPERTENSION Anita Ralstin, FNP-BC Next Step Health Consultant, LLC Incidence Of Hypertension About 70 million American adults have high blood pressure. About 33% of the population Only 52% have

More information

Incidental Findings; Management of patients presenting with high BP. Phil Swales

Incidental Findings; Management of patients presenting with high BP. Phil Swales Incidental Findings; Management of patients presenting with high BP Phil Swales Consultant Physician Acute & General Medicine University Hospitals of Leicester NHS Trust Objectives The approach to an incidental

More information

Hypertension Update Clinical Controversies Regarding Age and Race

Hypertension Update Clinical Controversies Regarding Age and Race Hypertension Update Clinical Controversies Regarding Age and Race Allison Helmer, PharmD, BCACP Assistant Clinical Professor Auburn University Harrison School of Pharmacy July 22, 2017 DISCLOSURE/CONFLICT

More information

The Latest Generation of Clinical

The Latest Generation of Clinical The Latest Generation of Clinical Guidelines: HTN and HLD Dave Brackett Clinical Guideline Purpose Uniform approach Awareness of key details Diagnosis Treatment Monitoring Evidence based approach Inform

More information

Hypertension. Most important public health problem in developed countries

Hypertension. Most important public health problem in developed countries Hypertension Strategy for Continued Success in Treatment for the 21st Century November 15, 2005 Arnold B. Meshkov, M.D. Associate Professor of Medicine Temple University School of Medicine Philadelphia,

More information

Management of Hypertension

Management of Hypertension Clinical Practice Guidelines Management of Hypertension Definition and classification of blood pressure levels (mmhg) Category Systolic Diastolic Normal

More information

A CASE OF HYPERTENSION AND ACUTE RENAL FAILURE OBJECTIVES

A CASE OF HYPERTENSION AND ACUTE RENAL FAILURE OBJECTIVES A CASE OF HYPERTENSION AND ACUTE RENAL FAILURE Maricel Pilapil-Pureza WLA Nephrology OBJECTIVES After the presentation, the attendee will be able to: 1. Discuss when to suspect for secondary causes of

More information

Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept

Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept Continents 1- introduction 2- classification/definition 3- classification/etiology 4-etiology in both categories 5- complications

More information

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension Prevalence of Hypertension Hypertension: Diagnosis and Management T. Villela, M.D. Program Director University of California, San Francisco-San Francisco General Hospital Family and Community Medicine

More information

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys

More information

Hypertension. Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute

Hypertension. Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute Hypertension Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute Hypertension 2017 Classification BP Category Systolic Diastolic Normal 120 and 80 Elevated

More information

Agenda. Management of Accelerated Hypertension (Updated in 2017) Salwa Roshdy Prof. of Cardiology Assiut University CardioEgypt 23/2/2017 2/27/2017

Agenda. Management of Accelerated Hypertension (Updated in 2017) Salwa Roshdy Prof. of Cardiology Assiut University CardioEgypt 23/2/2017 2/27/2017 Management of Accelerated Hypertension (Updated in 2017) By Salwa Roshdy Prof. of Cardiology Assiut University CardioEgypt 23/2/2017 Agenda Definition of Accelerated HTN Pathophysiology & Etiology Prognosis

More information

Endocrine. Endocrine as it relates to the kidney. Sarah Elfering, MD University of Minnesota

Endocrine. Endocrine as it relates to the kidney. Sarah Elfering, MD University of Minnesota Endocrine Sarah Elfering, MD University of Minnesota Endocrine as it relates to the kidney Parathyroid gland Vitamin D Endocrine causes of HTN Adrenal adenoma PTH Bone Kidney Intestine 1, 25 OH Vitamin

More information

What in the World is Functional Medicine?

What in the World is Functional Medicine? What in the World is Functional Medicine? An Introduction to a Systems Based Approach of Chronic Disease Meneah R Haworth, FNP-C Disclosure v I am a student of the Institute for Functional Medicine. They

More information

Getting BP to goal: Virginia L. Hood MB.BS, MPH, FACP

Getting BP to goal: Virginia L. Hood MB.BS, MPH, FACP Getting BP to goal: Virginia L. Hood MB.BS, MPH, FACP Objectives: Outline pathophysiological processes that sustain high BP Design individual treatment strategies for BP not at goal Facilitate patient

More information

HYPERTENSION. Background for understanding the Hypertension literature. Case presentation. Approach to Treatment. Jeffrey J. Kaufhold, MD Nephrology

HYPERTENSION. Background for understanding the Hypertension literature. Case presentation. Approach to Treatment. Jeffrey J. Kaufhold, MD Nephrology HYPERTENSION Background for understanding the Hypertension literature. Case presentation Approach to Treatment Jeffrey J. Kaufhold, MD Nephrology 2009 HYPERTENSION SUMMARY Background for understanding

More information

Blood Pressure Treatment in 2018

Blood Pressure Treatment in 2018 Blood Pressure Treatment in 2018 Jay D. Geoghagan, MD, FACC Disclosures: None 1 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management

More information

Hypertension Epidemiology 6% of deaths worldwide Defined as any of the following: systolic blood pressure 140 mmhg, diastolic blood pressure 90 mmhg, taking antihypertensive medications Pulse pressure=

More information

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured. Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.

More information

Difficult to Control HTN: It is not all the same. Structured approach to evaluation and treatment

Difficult to Control HTN: It is not all the same. Structured approach to evaluation and treatment Difficult to Control HTN: It is not all the same. Structured approach to evaluation and treatment Dmitri Vasin M.D. Nephrologist and ASH certified clinical hypertension specialist Bremerton, WA, USA Johnson

More information

Creative blood pressure management: whys and the tricks

Creative blood pressure management: whys and the tricks Creative blood pressure management: whys and the tricks Cynthia D. Caraballo-Hunt, MD Kaiser/OHSU Family Medicine Faculty Beaverton Medical Office NW Permanente, Portland, OR Objectives 1. Describe current

More information

We are delighted to have Dr. Roetzheim with us today to discuss Managing Hypertension in Older Adult Patients.

We are delighted to have Dr. Roetzheim with us today to discuss Managing Hypertension in Older Adult Patients. Richard Roetzheim, MD, MSPH is Professor and Chair, Department of Family Medicine at the University of South Florida Morsani College of Medicine. Dr. Roetzheim has considerable experience leading NIH funded

More information

Management of Hypertension in Women

Management of Hypertension in Women Management of Hypertension in Women Eliseo J. Pérez-Stable MD Professor of Medicine DGIM, Department of Medicine July 1, 2013 Declaration of full disclosure: No conflict of interest (I have never been

More information

Hypertension in the Era of ACC/AHA: Practice Changing Evidence and Recommendations

Hypertension in the Era of ACC/AHA: Practice Changing Evidence and Recommendations Hypertension in the Era of ACC/AHA: Practice Changing Evidence and Recommendations Gerald W. Smetana, M.D., MACP Division of General Medicine Beth Israel Deaconess Medical Center Professor of Medicine

More information

RESISTANT HYPERTENSION

RESISTANT HYPERTENSION RESISTANT HYPERTENSION John D. Bisognano, MD PhD Professor of Medicine / Cardiology President-Elect, American Society of Hypertension Director, Outpatient Cardiology University of Rochester RESISTANT HYPERTENSION

More information

Summary of recommendations

Summary of recommendations Summary of recommendations Measuring blood pressure (BP) Use the recommended technique at every BP reading to ensure accurate measurements and avoid common errs. Pay particular attention to the following:

More information

Dr Doris M. W Kinuthia

Dr Doris M. W Kinuthia Dr Doris M. W Kinuthia Objectives Normal blood pressures in children Measurement of blood pressure in children Aetiology of Hypertension in children Evaluation of children with hypertension Treatment of

More information

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Disclosure No relevant

More information

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories Chapter 23 Drugs for Hypertension Slide 37 Slide 41 Media Directory Nifedipine Animation Doxazosin Animation Upper Saddle River, New Jersey 07458 All rights reserved. Cardiovascular Disease (CVD) Includes

More information

Hypertension Cases. Katharine Dahl, MD January 10, 2017

Hypertension Cases. Katharine Dahl, MD January 10, 2017 Hypertension Cases Katharine Dahl, MD January 10, 2017 Dr. Dahl arrives late for her AHD hypertension lecture and you are asked to present the epidemiology of hypertension until she arrives. Which of the

More information

How to Recognize Adrenal Disease

How to Recognize Adrenal Disease How to Recognize Adrenal Disease CME Away India & Sri Lanka March 23 - April 7, 2018 Richard A. Bebb MD, ABIM, FRCPC Consultant Endocrinologist Medical Subspecialty Institute Cleveland Clinic Abu Dhabi

More information

5.2 Key priorities for implementation

5.2 Key priorities for implementation 5.2 Key priorities for implementation From the full set of recommendations, the GDG selected ten key priorities for implementation. The criteria used for selecting these recommendations are listed in detail

More information

Hypertension Management: A Moving Target

Hypertension Management: A Moving Target 9:45 :30am Hypertension Management: A Moving Target SPEAKER Karol Watson, MD, PhD, FACC Presenter Disclosure Information The following relationships exist related to this presentation: Karol E. Watson,

More information

What is hypertension?

What is hypertension? HYPERTENSION What is hypertension? Abnormally elevated arterial blood pressure that is usually indicated by an adult systolic blood pressure of 140 mm Hg or greater or a diastolic blood pressure of 90

More information

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B) Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed

More information

Hypertensive Crises. Controlling high blood pressure prevents disease. Recognition and Management of Acute Hypertensive Emergencies

Hypertensive Crises. Controlling high blood pressure prevents disease. Recognition and Management of Acute Hypertensive Emergencies Controlling high blood pressure prevents disease Recognition and Management of Acute Hypertensive Emergencies David idweiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Functional Genomics

More information

Antihypertensive Agents

Antihypertensive Agents Antihypertensive Agents Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 7, 08, presented by Ezra Levy, Pharm.D! Usual Dose,

More information

Hypertension 2015: Recent Evidence that Will Change Your Practice

Hypertension 2015: Recent Evidence that Will Change Your Practice Hypertension 2015: Recent Evidence that Will Change Your Practice Gerald W. Smetana, M.D. Division of General Medicine Beth Israel Deaconess Medical Center Professor of Medicine Harvard Medical School

More information

Approach to Adrenal Incidentaloma. Alice Y.Y. Cheng, MD, FRCP

Approach to Adrenal Incidentaloma. Alice Y.Y. Cheng, MD, FRCP Approach to Adrenal Incidentaloma Alice Y.Y. Cheng, MD, FRCP Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form

More information

major public health burden

major public health burden HYPERTENSION INTRODUCTION Hypertension is one of the major public health burden in the recent times. Hypertension remains a challenging medical condition among the noncommunicable diseases of ever growing

More information

2014 HYPERTENSION GUIDELINES

2014 HYPERTENSION GUIDELINES 2014 HYPERTENSION GUIDELINES Eileen M. Twomey, Pharm.D., BCPS 1 Learning Objectives Describe specific blood pressure thresholds at which antihypertensive therapy should be initiated and blood pressure

More information

Objectives. Heart failure and Hypertension. Definition & epidemiology of heart failure HEART FAILURE 3/12/2016. Kirsten Bibbins-Domingo, PhD, MD, MAS

Objectives. Heart failure and Hypertension. Definition & epidemiology of heart failure HEART FAILURE 3/12/2016. Kirsten Bibbins-Domingo, PhD, MD, MAS Objectives Heart failure and Hypertension Kirsten Bibbins-Domingo, PhD, MD, MAS Lee Goldman, MD Endowed Chair in Medicine Professor of Medicine and of Epidemiology and Biostatistics University of California,

More information

The New Hypertension Guidelines

The New Hypertension Guidelines The New Hypertension Guidelines Joseph Saseen, PharmD Professor and Vice Chair, Department of Clinical Pharmacy University of Colorado Anschutz Medical Campus Disclosure Joseph Saseen reports no conflicts

More information

Practical Aspects of Hypertension: Simple Strategies to Help You and Your Patients Meet Guideline Blood Pressure Targets

Practical Aspects of Hypertension: Simple Strategies to Help You and Your Patients Meet Guideline Blood Pressure Targets Practical Aspects of Hypertension: Simple Strategies to Help You and Your Patients Meet Guideline Blood Pressure Targets Robert J. Herman University of Calgary herman@ucalgary.ca Conflict of Interest Disclosure

More information

Hypertensives Emergency and Urgency

Hypertensives Emergency and Urgency Hypertensives Emergency and Urgency Budi Yuli Setianto Cardiology Divisision Department of Internal Medicine Faculty of Medicine UGM Sardjito Hospital Yogyakarta Background USA: Hypertension is 30% of

More information

Combination Therapy for Hypertension

Combination Therapy for Hypertension Combination Therapy for Hypertension Se-Joong Rim, MD Cardiology Division, Yonsei University College of Medicine, Seoul, Korea Goals of Therapy Reduce CVD and renal morbidity and mortality. Treat to BP

More information

Joshua M. Crasner,DO,FACC,FACOI

Joshua M. Crasner,DO,FACC,FACOI Joshua M. Crasner,DO,FACC,FACOI 50 million people USA SBP>115 incr risk CAD/CVA Q 20mm incr=2x risk JNC-8 almost changed aggressive Tx Pseudo-HTN Hypertension 2015 2 Most common HBP( > 90 %)--multifactorial

More information

Adult Blood Pressure Clinician Guide June 2018

Adult Blood Pressure Clinician Guide June 2018 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Adult Blood Pressure Clinician Guide June 2018 Adult Blood Pressure Clinician Guide June 2018 Introduction This Clinician Guide is based on the 2018

More information

SECONDARY HYPERTENSION

SECONDARY HYPERTENSION SECONDARY HYPERTENSION Grand round for Medical student 25 October 2013 By Rungnapa Laortanakul, MD. OUTLINE Overview of HT Secondary HT Resistance HT Primary aldosteronism Pheochromocytoma Cushing s syndrome

More information

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Management of Lipid Disorders and Hypertension Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine

More information

How do I investigate suspected secondary hypertension? Marie Freel RCP Update in Medicine 23 rd November 2016

How do I investigate suspected secondary hypertension? Marie Freel RCP Update in Medicine 23 rd November 2016 How do I investigate suspected secondary hypertension? Marie Freel RCP Update in Medicine 23 rd November 2016 World beaters..! Michel Joffres et al. BMJ Open 2013;3:e003423 Hypertension often poorly controlled

More information

Network Hypertension Algorithm

Network Hypertension Algorithm Network Hypertension Algorithm Content Review and Approval: This document is subject to review, revision, and (re)approval by the Clinical Integration and Oversight Committee (CIOC) annually and following

More information

INDIAN HYPERTENSION GUIDELINES-II

INDIAN HYPERTENSION GUIDELINES-II HYPERTENSION IN SPECIAL SITUATIONS Hypertension with diabetes mellitus Co-existence of hypertension and diabetes is being increasingly recognised. 30-35% of hypertensives are detected to have diabetes.

More information

Diseases of the Adrenal gland

Diseases of the Adrenal gland Diseases of the Adrenal gland Adrenal insufficiency Cushing disease vs syndrome Pheochromocytoma Hyperaldostronism What are the layers of the adrenal gland?? And what does each layer produce?? What are

More information